Company News
OneSource Partner Orbicular Gets Tentative Ozempic ANDA Approval
OneSource's partner Orbicular secured tentative US FDA ANDA approval for generic Ozempic (Semaglutide Injection).
OneSource served as CDMO partner providing end-to-end manufacturing from its US-FDA ap
